Alexandra Collingbourne Alexandra Collingbourne

Arecor wins £2.8m from Innovate UK to boost fight against diabetes

Cambridge biopharma business Arecor has been awarded a £2.8 million grant from Innovate UK to support the Phase II development of AT247, an ultra-rapid acting insulin product candidate based on Arecor’s proprietary Arestat technology platform.

Read More
Alexandra Collingbourne Alexandra Collingbourne

Psyomics pilots digital mental health assessment Censeo

UK healthtech firm Psyomics has begun pilots of its mental health assessment platform Censeo in two London GP practices, gathering real-world data and feedback before commercial launch later this year.

Read More